CN105495206A - 给身体充电的植物活力饮料及其制备方法 - Google Patents
给身体充电的植物活力饮料及其制备方法 Download PDFInfo
- Publication number
- CN105495206A CN105495206A CN201510915914.5A CN201510915914A CN105495206A CN 105495206 A CN105495206 A CN 105495206A CN 201510915914 A CN201510915914 A CN 201510915914A CN 105495206 A CN105495206 A CN 105495206A
- Authority
- CN
- China
- Prior art keywords
- plant
- stoste
- water
- citric acid
- beverage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 10
- 235000015897 energy drink Nutrition 0.000 title abstract 6
- 241000196324 Embryophyta Species 0.000 claims abstract description 42
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 22
- 239000000203 mixture Substances 0.000 claims abstract description 21
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims abstract description 21
- 235000015097 nutrients Nutrition 0.000 claims abstract description 20
- SEBIKDIMAPSUBY-ARYZWOCPSA-N Crocin Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)C(C)=CC=CC(C)=C\C=C\C=C(/C)\C=C\C=C(C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)O1)O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SEBIKDIMAPSUBY-ARYZWOCPSA-N 0.000 claims abstract description 19
- 239000009627 gardenia yellow Substances 0.000 claims abstract description 15
- 235000021552 granulated sugar Nutrition 0.000 claims abstract description 13
- 235000020710 ginseng extract Nutrition 0.000 claims abstract description 12
- 229960003080 taurine Drugs 0.000 claims abstract description 11
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims abstract description 10
- 229960000367 inositol Drugs 0.000 claims abstract description 10
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims abstract description 10
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims abstract description 10
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims abstract description 10
- 235000019158 vitamin B6 Nutrition 0.000 claims abstract description 10
- 239000011726 vitamin B6 Substances 0.000 claims abstract description 10
- 229940011671 vitamin b6 Drugs 0.000 claims abstract description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 10
- 235000020733 paullinia cupana extract Nutrition 0.000 claims abstract description 9
- 239000000843 powder Substances 0.000 claims abstract description 9
- 230000001954 sterilising effect Effects 0.000 claims abstract description 7
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 48
- 235000013361 beverage Nutrition 0.000 claims description 26
- 230000036541 health Effects 0.000 claims description 23
- 238000010790 dilution Methods 0.000 claims description 14
- 239000012895 dilution Substances 0.000 claims description 14
- 235000009754 Vitis X bourquina Nutrition 0.000 claims description 12
- 235000012333 Vitis X labruscana Nutrition 0.000 claims description 12
- 235000014787 Vitis vinifera Nutrition 0.000 claims description 12
- 239000007788 liquid Substances 0.000 claims description 10
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 9
- 241000219780 Pueraria Species 0.000 claims description 8
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 8
- 235000005152 nicotinamide Nutrition 0.000 claims description 8
- 239000011570 nicotinamide Substances 0.000 claims description 8
- 229960003966 nicotinamide Drugs 0.000 claims description 8
- 239000006228 supernatant Substances 0.000 claims description 8
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 7
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 7
- 235000010447 xylitol Nutrition 0.000 claims description 7
- 239000000811 xylitol Substances 0.000 claims description 7
- 229960002675 xylitol Drugs 0.000 claims description 7
- 230000008859 change Effects 0.000 claims description 4
- 238000011049 filling Methods 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 3
- 239000000047 product Substances 0.000 claims description 3
- 241000235342 Saccharomycetes Species 0.000 claims description 2
- 238000000034 method Methods 0.000 claims description 2
- 240000006365 Vitis vinifera Species 0.000 claims 4
- 235000000421 Lepidium meyenii Nutrition 0.000 abstract description 5
- 235000012902 lepidium meyenii Nutrition 0.000 abstract description 5
- 230000002401 inhibitory effect Effects 0.000 abstract description 3
- YASYEJJMZJALEJ-UHFFFAOYSA-N Citric acid monohydrate Chemical compound O.OC(=O)CC(O)(C(O)=O)CC(O)=O YASYEJJMZJALEJ-UHFFFAOYSA-N 0.000 abstract description 2
- 206010015150 Erythema Diseases 0.000 abstract description 2
- 240000000759 Lepidium meyenii Species 0.000 abstract description 2
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 abstract 1
- 229960002303 citric acid monohydrate Drugs 0.000 abstract 1
- 238000005352 clarification Methods 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 230000003902 lesion Effects 0.000 abstract 1
- 239000001509 sodium citrate Substances 0.000 abstract 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 abstract 1
- 238000004659 sterilization and disinfection Methods 0.000 abstract 1
- 230000001502 supplementing effect Effects 0.000 abstract 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 18
- 230000000694 effects Effects 0.000 description 16
- 230000006870 function Effects 0.000 description 15
- 240000004371 Panax ginseng Species 0.000 description 13
- 235000008434 ginseng Nutrition 0.000 description 13
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 12
- 235000003140 Panax quinquefolius Nutrition 0.000 description 12
- 235000000556 Paullinia cupana Nutrition 0.000 description 12
- 240000003444 Paullinia cupana Species 0.000 description 12
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 12
- 241000219095 Vitis Species 0.000 description 8
- 235000016709 nutrition Nutrition 0.000 description 8
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 229960001948 caffeine Drugs 0.000 description 6
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 6
- 206010012601 diabetes mellitus Diseases 0.000 description 6
- 235000013305 food Nutrition 0.000 description 6
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 6
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- 230000006872 improvement Effects 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- SEBIKDIMAPSUBY-JAUCNNNOSA-N Crocin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C(=O)OC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)C=CC=C(/C)C(=O)OC3OC(COC4OC(CO)C(O)C(O)C4O)C(O)C(O)C3O SEBIKDIMAPSUBY-JAUCNNNOSA-N 0.000 description 4
- 150000001336 alkenes Chemical class 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 230000003078 antioxidant effect Effects 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 229920001864 tannin Polymers 0.000 description 4
- 235000018553 tannin Nutrition 0.000 description 4
- 239000001648 tannin Substances 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 208000024172 Cardiovascular disease Diseases 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 102000004877 Insulin Human genes 0.000 description 3
- 108090001061 Insulin Proteins 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 238000004040 coloring Methods 0.000 description 3
- 229920002770 condensed tannin Polymers 0.000 description 3
- 230000035558 fertility Effects 0.000 description 3
- 235000002864 food coloring agent Nutrition 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 229940125396 insulin Drugs 0.000 description 3
- 238000002372 labelling Methods 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 229960003512 nicotinic acid Drugs 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 230000007170 pathology Effects 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 150000008442 polyphenolic compounds Chemical class 0.000 description 3
- 235000013824 polyphenols Nutrition 0.000 description 3
- 239000003765 sweetening agent Substances 0.000 description 3
- 229940098465 tincture Drugs 0.000 description 3
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 2
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- 150000003797 alkaloid derivatives Chemical class 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000001775 anti-pathogenic effect Effects 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 229910052785 arsenic Inorganic materials 0.000 description 2
- 230000006399 behavior Effects 0.000 description 2
- MDKCFLQDBWCQCV-UHFFFAOYSA-N benzyl isothiocyanate Chemical compound S=C=NCC1=CC=CC=C1 MDKCFLQDBWCQCV-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 235000012970 cakes Nutrition 0.000 description 2
- 235000021466 carotenoid Nutrition 0.000 description 2
- 150000001747 carotenoids Chemical class 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000012627 chemopreventive agent Substances 0.000 description 2
- 229940124443 chemopreventive agent Drugs 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 235000021393 food security Nutrition 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 210000005075 mammary gland Anatomy 0.000 description 2
- 235000001968 nicotinic acid Nutrition 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 235000021283 resveratrol Nutrition 0.000 description 2
- 229940016667 resveratrol Drugs 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- YAPQBXQYLJRXSA-UHFFFAOYSA-N theobromine Chemical compound CN1C(=O)NC(=O)C2=C1N=CN2C YAPQBXQYLJRXSA-UHFFFAOYSA-N 0.000 description 2
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 2
- 229910052718 tin Inorganic materials 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010001497 Agitation Diseases 0.000 description 1
- 208000007848 Alcoholism Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 206010003211 Arteriosclerosis coronary artery Diseases 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 206010006179 Breast atrophy Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000017897 Carcinoma of esophagus Diseases 0.000 description 1
- 206010007559 Cardiac failure congestive Diseases 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 241001070941 Castanea Species 0.000 description 1
- 235000014036 Castanea Nutrition 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 244000111489 Gardenia augusta Species 0.000 description 1
- 235000018958 Gardenia augusta Nutrition 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 206010060891 General symptom Diseases 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 208000037319 Hepatitis infectious Diseases 0.000 description 1
- 206010061216 Infarction Diseases 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- QAADZYUXQLUXFX-UHFFFAOYSA-N N-phenylmethylthioformamide Natural products S=CNCC1=CC=CC=C1 QAADZYUXQLUXFX-UHFFFAOYSA-N 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 235000002789 Panax ginseng Nutrition 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000028017 Psychotic disease Diseases 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003537 Vitamin B3 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000036982 action potential Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 201000007930 alcohol dependence Diseases 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 230000000386 athletic effect Effects 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 229960000074 biopharmaceutical Drugs 0.000 description 1
- 150000005693 branched-chain amino acids Chemical class 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 235000001465 calcium Nutrition 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000023652 chronic gastritis Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000003001 depressive effect Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 235000018927 edible plant Nutrition 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 229940107131 ginseng root Drugs 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 125000004383 glucosinolate group Chemical group 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 230000010224 hepatic metabolism Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 208000005252 hepatitis A Diseases 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 229920001461 hydrolysable tannin Polymers 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 210000003016 hypothalamus Anatomy 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000007574 infarction Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 229910052745 lead Inorganic materials 0.000 description 1
- 201000010260 leiomyoma Diseases 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 235000011475 lollipops Nutrition 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 210000000663 muscle cell Anatomy 0.000 description 1
- 201000006938 muscular dystrophy Diseases 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 235000019520 non-alcoholic beverage Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 230000037081 physical activity Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 235000002378 plant sterols Nutrition 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 206010036596 premature ejaculation Diseases 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- LUKBXSAWLPMMSZ-UHFFFAOYSA-N resveratrol Chemical compound C1=CC(O)=CC=C1C=CC1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-UHFFFAOYSA-N 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000019100 sperm motility Effects 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 201000000498 stomach carcinoma Diseases 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 235000021092 sugar substitutes Nutrition 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229960004559 theobromine Drugs 0.000 description 1
- 229960000278 theophylline Drugs 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019160 vitamin B3 Nutrition 0.000 description 1
- 239000011708 vitamin B3 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/56—Flavouring or bittering agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/60—Sweeteners
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Non-Alcoholic Beverages (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
一种给身体充电的植物活力饮料及其制备方法,其重量组份及制备方法如下:先将水1000-1020、白砂糖120-140、一水柠檬酸3.5-3.9、柠檬酸纳1.84-1.88、牛磺酸0.4-0.6、肌醇0.08-1.2、烟酰胺0.008-0.012、维生素B60.0008-0.0012制取稀释营养素原液,再加入瓜拉纳提取物1.7-2.1、人参提取物0.072-0.076、水溶性玛咖粉0.03-0.05、栀子黄0.05-0.09、葡萄皮红0.037-0.041、植物杂果香精0.0880-0.0884。经澄清灭菌后制得。其优点是可对人体的生物电能和细胞营养及人体所需能量进行综合补充,有效调解人体亚健康状态和抑制病变即给身体充电,从而有效调解人体亚健康状态和抑制病变即给身体充电。
Description
技术领域
本发明涉及非酒精饮料及其制备,特别涉及给身体充电的植物活力饮料及其制备方法。
背景技术
目前,传统功能饮料中,因大都含有人工合成防腐剂苯甲酸钠或山梨酸钾,人工合成色素胭脂红或日落黄,甜味剂阿斯巴甜,人工合成咖啡因,部分维生素超标而或多或少出现着食品安全现象。客观上讲,其各种原料和添加剂及配比含量虽然都符合国家相关标准,但放眼欧美标准,我国的饮料配方和安全问题亟需颠覆和改变。
发明内容
针对现有技术的缺点,本发明的目的在于提供一种给身体充电的植物活力饮料及其制备方法。解决传统功能饮料中因人工合成防腐剂、人工合成色素、人工合成甜味剂等给人体所带来的食品安全隐患问题;解决传统功能饮料中单一性依赖咖啡因或基本营养素而“亡羊补牢”式“治标不治本”的单一补充问题;解决饮料品类国际化、标准化、多元化的问题;弘扬中医草本理论。
本发明解决其技术问题所采用的技术方案是:提供一种给身体充电的植物活力饮料及其制备方法,所述给身体充电的植物活力饮料的特征在于包括如下重量组份(非百分比):水1000-1020、白砂糖120-140、一水柠檬酸3.5-3.9、柠檬酸纳1.84-1.88、牛磺酸0.4-0.6、肌醇0.08-1.2、烟酰胺0.008-0.012、维生素B60.0008-0.0012、瓜拉纳提取物1.7-2.1、人参提取物0.072-0.076、水溶性玛咖粉0.03-0.05、栀子黄0.05-0.09、葡萄皮红0.037-0.041、植物杂果香精0.0880-0.0884。
依据上述重量组份,所述给身体充电的植物活力饮料制备方法包括如下步骤:
①制作稀释营养素原液:将水、白砂糖、一水柠檬酸、柠檬酸纳、牛磺酸、肌醇、烟酰胺与维生素B6混合均匀,制成稀释营养素原液。
②在上述稀释营养素原液中加入瓜拉纳提取物、人参提取物、水溶性玛咖粉、栀子黄、葡萄皮红、植物杂果香精,经充分混匀后进行澄清处理,使性状为澄清液体。
③将上述澄清液体灭菌,进行灌装,检测合格即为成品。
本发明包含基础营养素原液、瓜拉纳因(Guaranaine)、玛咖烯(maceaene)和玛咖酰胺(mecamide)、人参酊(Ginsengextract)。在基础营养素原液中加入含瓜拉纳因(Guaranaine)、玛咖烯(maceaene)和玛咖酰胺(mecamide)、人参酊(Ginsengextract)的巴西瓜拉纳、秘鲁玛咖和长白山人参的可溶水性植物提取物,是对传统功能饮料的一项重大突破性改进。即以植物天然成分颠覆取代人工合成成分。
A、瓜拉纳因Guaranaine:化学成份几乎等同于咖啡因但性能功效又区别于咖啡因,1993年国际生物药学杂志(Houghton,PJ,BempongandSteadman)VanStraten博士认为,瓜拉纳因是咖啡因、可可碱、茶碱、烟酸和其他化合物的混合使得瓜拉纳具有它独特的效应。瓜拉纳种子的全部提取物比等剂量的人参提取物或咖啡因有更强的效力且安全无毒副作用。(a)瓜拉纳含有昂贵和丰富的高脂蛋白、矿物质、葡萄糖、氨基酸、脂肪酸、多种维生素,对细胞生长与器官的构成起着非常重要的作用。(b)瓜拉纳能降低高胆固醇、脂肪酸、调整血液循环。可主动补充人体各部细胞营养,促进生长发育和防止器官老化。(c)瓜拉纳能活化纤维蛋白的溶解作用,有效改善脑部血管和血管阻塞症所引起的各种病变,并能刺激心跳,强壮心脏,能有效预防心肌梗塞和心脏衰弱。(d)瓜拉纳有提高体能和抗疲劳的功能;有减轻体重的作用;能增强在高压力下的生理承受力,对改善行为情绪和信心有强烈而持久地作用;能增强记忆力。(e)瓜拉纳对“血液健康”很好,可减少因血小板的聚集而引起的中风。
B、玛咖(Maca):玛咖烯(maceaene)和玛咖酰胺(mecamide)是玛咖(MACA)提取物中具促进性功能的有效物质。玛咖,是世界上唯一一种能同时“阴阳互补”且无任何毒副作用的植物良药。也被称为“植物伟哥”。(a)玛咖具提高生育力、改善性功能、抗癌、抗白血病、治疗更年期综合症等作用。(b)玛咖(MACA)中的生物碱成分具抗菌、抗病毒、抗血凝、镇痛、抗炎症、抗肿瘤和抗心血管疾病等作用,因而可用于免疫功能下降、更年期综合症、子宫肌瘤、乳腺增生、慢性心脑血管病等的治疗。(c)玛咖全面均衡的营养成分和独有的活力营养素物质,能有效坚固免疫系统,改善亚健康状态。玛咖中不饱和脂肪酸、亚油酸和亚麻酸含量较高,有抗氧化,降血脂,防止动脉硬化的功效。(d)防癌抗肿瘤:玛咖中含有芥子油苷、异硫氰酸苄酯等含硫有机化合物,多种不饱和脂肪酸和维生素C具有抗癌效果,对胃癌、食道癌、肺癌、白血病等均有抑制作用。(c)玛咖中含牛磺酸、谷氨酸、精氨酸、植物多酚等物质,具有提高肝脏代谢的功能,能加速乙醇和乙醛的代谢,防止酒精中毒,加速体内重金属、农药残留的排泄,对脂肪肝、酒精肝、肝纤维化,高血糖等有防治作用。(d)玛咖含有较高含量的铁、蛋白质、氨基酸、钙、维生素B12等营养成分,对缺铁性贫血、骨质疏松有很好的作用。(e)玛咖中含有均衡的植物活性营养成分支链氨基酸、植物类固醇、甾醇等物质,长期服用可有效提高运动员的竞技水平,迅速消除疲劳,增强肌肉运动能力,降低运动损伤,挑战人类运动的生理极限。(f)改善性功能,提高生育能力:玛咖独有的玛咖烯、玛咖酰胺可调节人的下丘脑,促使荷尔蒙的分泌达到正常水平,对改善性功能障碍、男性精子数量减少、精子活力差、男女生育能力下降、女性月经不调、乳腺增生、乳房萎缩、更年期综合症有明显效果。
C、人参:Panaxginseng,是亚洲常见药材,人参根部所含皂苷是其有效成分。(a)人参对于高血压病、心肌营养不良、冠状动脉硬化、心绞痛等,都有一定时效的治疗作用,可以减轻各种症状。(b)人参可使慢性胃炎病人胃痛消失,食欲增强,胃液总酸度增加。对于急性传染性肝炎,在一定的治疗条件下,服用人参对于防止转变为慢性肝炎似有一定的积极作用。(c)人参能改善糖尿病人的一般症状,可使轻型糖尿病患者尿糖减少,血糖降低;中度糖屎病人多数全身状况有所改善,如渴感等症状消失或减轻;某些患者可起到减少胰岛素用量的作用。(d)人参对神经系统有显著的兴奋作用,能提高机体活动能力,减少疲劳;对不同类型的神经衰弱患者均有一定的治疗作用,可消除或减轻全身无力、头痛、失眠等症状。对无力型和无力抑郁型精神病均有治疗作用。(e)人参为强壮剂,可以补养元气,有增强性腺机能的作用。人参酊对于麻痹型、早泄型阳痿有显著的疗效,但对精神型无效;对因神经衰弱所引起的皮层性和脊髓性阳痿也有一定治疗效果。(f)人参还有提高视力及增强视觉暗适应的作用。
本发明植物活力饮料,加入天然色素葡萄皮红和栀子黄,是倡导绿色健康,关注天然色素在食品饮料中的应用,将“饮”导新的消费时尚,是对传统功能饮料的一次“绿色革命”。即以植物天然色素颠覆取代人工合成色素。
A、葡萄皮红中含有单宁(Tannins)成分和白藜芦醇(Resveratrol),单宁是多酚中高度聚合的化合物,可分为水解单宁(hydrolytictannin,HT)和缩合单宁(condensedtannin,CT),两者常共存,后者也称原花青素(proanthocyanidins)。自20世纪50年代后,它的抗氧化、捕捉自由基、抑菌、衍生化反应的行为被揭示后,其应用前景和范围迅速扩大,在食品加工、果蔬加工、贮藏、医药和水处理等方面已取得重要突破。白藜芦醇是一种生物性很强的天然多酚类物质,又称为芪三酚,是肿瘤的化学预防剂,也是对降低血小板聚集,预防和治疗动脉粥样硬化、心脑血管疾病的化学预防剂。B、栀子黄(crocin,gardeniayellow),别名藏花素,俗称黄栀子,属类胡萝卜素系列,它是栀子中的黄色色素,其黄色素成分为类胡萝卜类色素的藏花素,与藏红花中的藏花素相同。分子式为C44H64O24,相对分子质量976.97。栀子黄可用于果汁(味)型饮料、配制酒、糕点上彩妆、冰棍、雪糕、膨化食品、果冻、面饼、糖果和栗子罐头等。桅子黄色素可作为抗氧化剂和着色剂应用于食品工业中。除此之外,又含有一定的和血、活血、祛疲、止痛、降压等医疗价值。
本发明植物活力饮料,倡导的是植物天然抑菌成分的天然防腐,是对传统功能饮料的一次颠覆式“反腐”。即以植物天然防腐抑菌成分颠覆取代人工合成防腐剂。
加入的植物天然成分中,玛咖(MACA)中的生物碱成分具抗菌、抗病毒作用;葡萄皮红中的单宁具抗氧化、捕捉自由基、抑菌的作用;植物原料成分中的酚类化合物有强大的抑菌成分;加入的天然食用植物香精(杂果香精)中的天然抗菌(防腐)作用和抗菌性的协同增效作用;适当增加饮料的酸度(即降低PH值),细菌不易生长。
进一步地,将上述稀释营养素原液中的白砂糖改为木糖醇重量份为140-150,可适用于有肥胖症或高血压以及有糖尿病或有糖尿病家族遗传倾向的人群。
木糖醇也叫戊五醇,是一种五碳糖醇,分子式是C5H1205,是一种功能性甜味剂,不是人工合成的;木糖醇是人体糖类代谢的中间体,在体内缺少胰岛素影响糖代谢情况下,无需胰岛素促进,木糖醇也能透过细胞膜,被组织吸收利用,供细胞以营养和能量,且不会引起血糖值升高,消除糖尿病人服用后的三多症状(多食、多饮、多尿),是最适合糖尿病患者食用的营养性的食糖代替品。
本发明的有益效果是:可对人体的生物电能和细胞营养及人体所需能量进行综合补充,有效调解人体亚健康状态和抑制病变即给身体充电,可以被特别地开发用来补充人体机体最基本单位即细胞的所需营养和细胞生物电能量及细胞“兴奋性”反应和“动作电位”所需营养和能量,使细胞膜内外带电荷的“极地状态”处于优良的“生物电”工作状态,从而有效调解人体亚健康状态和抑制病变即给身体充电;即从中西医学上讲,能促进人体血液循环,改善人体微循环,调解人体阴阳平衡,促进新陈代谢,疏通人体经络,使气血畅通,提高人体免疫力和自我修复能力,激活神经细胞和肌肉细胞,恢复传导功能,促使细胞再生。以草本植物活力菁华(生物活性成分)和草本植物天然抑菌成分(植物天然防腐剂)为科学导向,倡导“绿色、营养、健康、安全”的饮食文化,关注新型绿色健康饮品,创新“植物活力饮料”新品类,“饮”领人们健康生活科学养生新潮。
具体实施方式
实施例一
本发明给身体充电的植物活力饮料按如下重量组份组成:水1000Kg,白砂糖130Kg,一水柠檬酸3.7Kg,柠檬酸纳1.86Kg,牛磺酸0.5Kg,肌醇0.1Kg,烟酰胺0.01Kg,维生素B60.001Kg,瓜拉纳提取物1.9Kg,人参提取物0.074Kg,水溶性玛咖粉0.04Kg,栀子黄0.0715Kg,葡萄皮红0.039Kg和植物杂果香精0.882Kg。
本发明依据上述重量组份的给身体充电的植物活力饮料的制备方法包括如下步骤:
①制作稀释营养素原液:将水1000Kg,白砂糖130Kg,一水柠檬酸3.7Kg,柠檬酸纳1.86Kg,牛磺酸0.5Kg,肌醇0.1Kg,烟酰胺0.01Kg,维生素B60.001Kg,用混合机混合均匀,制成稀释营养素原液;抽取310mL检测,检测结果中,肌醇(mg/kg)80,牛磺酸(g/kg)0.458,维生素B3(烟酸,mg/kg)9.18,维生素B6(以吡哆醇计,mg/kg)0.890,符合国家检测标准。
②在稀释营养素原液中加入瓜拉纳提取物1.9Kg,人参提取物0.074Kg,水溶性玛咖粉0.04Kg,栀子黄0.0715Kg,葡萄皮红0.039Kg,植物杂果香精0.882Kg,经气密式离心机进行澄清处理;得到澄清液体,抽取310mL检测,检测结果中,葡萄皮红(g/kg)<1.25×10﹣3,栀子黄(g/kg)<0.15,可溶性固形物(20℃,%)10.0,总酸(以一分子水柠檬酸计,g/L)3.80,总砷(以As计,mg/L)<0.10,铅(以Pb计,mg/L)<0.20,锡(以Sn计,mg/L)<0.50,PH值3.44,符合国家检测标准。
③将上述澄清液体经超高温瞬间灭菌机(UHT)8~15秒灭菌和罐(瓶)体的高温消毒灭菌,进行液体灌装。经检测,菌落总数(cfu/mL)<1,霉菌(cfu/mL)<1,酵母菌(cfu/mL)<1,大肠菌群(MPN/100mL)<3,符合国家检测标准。
实施例二
将上述稀释营养素原液中的原料白砂糖改为木糖醇144Kg其余组份不变。制作方法不变。
Claims (6)
1.一种给身体充电的植物活力饮料,其特征在于包括如下重量组份:水1000-1020、白砂糖120-140、一水柠檬酸3.5-3.9、柠檬酸纳1.84-1.88、牛磺酸0.4-0.6、肌醇0.08-1.2、烟酰胺0.008-0.012、维生素B60.0008-0.0012、瓜拉纳提取物1.7-2.1、人参提取物0.072-0.076、水溶性玛咖粉0.03-0.05、栀子黄0.05-0.09、葡萄皮红0.037-0.041、植物杂果香精0.0880-0.0884。
2.根据权利要求1所述的给身体充电的植物活力饮料的制备方法,其特征在于包括如下步骤:
①制作稀释营养素原液:将水、白砂糖、一水柠檬酸、柠檬酸纳、牛磺酸、肌醇、烟酰胺与维生素B6混合均匀,制成稀释营养素原液。
②在上述稀释营养素原液中加入瓜拉纳提取物、人参提取物、水溶性玛咖粉、栀子黄、葡萄皮红、植物杂果香精,经充分混匀后进行澄清处理,使性状为澄清液体。
③将上述澄清液体灭菌,进行灌装,检测合格即为成品。
3.根据权利要求1所述的给身体充电的植物活力饮料,其特征在于包括如下重量组份:水1000Kg,白砂糖130Kg,一水柠檬酸3.7Kg,柠檬酸纳1.86Kg,牛磺酸0.5Kg,肌醇0.1Kg,烟酰胺0.01Kg,维生素B60.001Kg,瓜拉纳提取物1.9Kg,人参提取物0.074Kg,水溶性玛咖粉0.04Kg,栀子黄0.0715Kg,葡萄皮红0.039Kg和植物杂果香精0.882Kg。
4.根据权利要求3所述的给身体充电的植物活力饮料制备方法,其特征在于包括如下步骤:
①制作稀释营养素原液:将水1000Kg,白砂糖130Kg,一水柠檬酸3.7Kg,柠檬酸纳1.86Kg,牛磺酸0.5Kg,肌醇0.1Kg,烟酰胺0.01Kg,维生素B60.001Kg,用混合机混合均匀,制成稀释营养素原液。
②在稀释营养素原液中加入瓜拉纳提取物1.9Kg,人参提取物0.074Kg,水溶性玛咖粉0.04Kg,栀子黄0.0715Kg,葡萄皮红0.039Kg,植物杂果香精0.882Kg,经气密式离心机进行澄清处理;得到澄清液体。
③将上述澄清液体经超高温瞬间灭菌机8~15秒灭菌和罐体的高温消毒灭菌,进行液体灌装,进行检测,菌落总数(cfu/mL)<1,霉菌(cfu/mL)<1,酵母菌(cfu/mL)<1,大肠菌群(MPN/100mL)<3,符合国家检测标准为合格产品。
5.根据权利要求1所述的给身体充电的植物活力饮料,其特征在于:将所述稀释营养素原液中的白砂糖改为木糖醇,重量份为140-150。
6.根据权利要求3所述的给身体充电的植物活力饮料,其特征在于:将所述稀释营养素原液中的白砂糖改为木糖醇,重量为144Kg。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510915914.5A CN105495206A (zh) | 2015-12-10 | 2015-12-10 | 给身体充电的植物活力饮料及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510915914.5A CN105495206A (zh) | 2015-12-10 | 2015-12-10 | 给身体充电的植物活力饮料及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105495206A true CN105495206A (zh) | 2016-04-20 |
Family
ID=55703816
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510915914.5A Pending CN105495206A (zh) | 2015-12-10 | 2015-12-10 | 给身体充电的植物活力饮料及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105495206A (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106902102A (zh) * | 2017-02-22 | 2017-06-30 | 武汉华士特工业生物技术开发有限公司 | 玛咖酰胺类化合物在制备治疗月经不调药物中的应用 |
CN106937721A (zh) * | 2017-02-07 | 2017-07-11 | 李冬 | 在功能饮料中添加人参提取物,用瓜拉纳或茶提取物替代咖啡因,并使用天然植物色素 |
EP3831213A1 (en) * | 2019-12-04 | 2021-06-09 | Vegastrade-Comércio de Perfumeria e Bijutaria, LDA | Non-carbonated beverage comprising aloe vera and plant extracts |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101574140A (zh) * | 2008-11-27 | 2009-11-11 | 厦门金日制药有限公司 | 一种具有增强人体免疫功能和抗疲劳作用的饮品组合物 |
CN102793243A (zh) * | 2012-08-15 | 2012-11-28 | 广州白云山潘高寿药业股份有限公司 | 用于亚健康调理的饮料及其制备方法 |
CN103564590A (zh) * | 2013-11-16 | 2014-02-12 | 丽江玛咖生物科技有限公司 | 玛咖饮料及其制备方法 |
-
2015
- 2015-12-10 CN CN201510915914.5A patent/CN105495206A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101574140A (zh) * | 2008-11-27 | 2009-11-11 | 厦门金日制药有限公司 | 一种具有增强人体免疫功能和抗疲劳作用的饮品组合物 |
CN102793243A (zh) * | 2012-08-15 | 2012-11-28 | 广州白云山潘高寿药业股份有限公司 | 用于亚健康调理的饮料及其制备方法 |
CN103564590A (zh) * | 2013-11-16 | 2014-02-12 | 丽江玛咖生物科技有限公司 | 玛咖饮料及其制备方法 |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106937721A (zh) * | 2017-02-07 | 2017-07-11 | 李冬 | 在功能饮料中添加人参提取物,用瓜拉纳或茶提取物替代咖啡因,并使用天然植物色素 |
CN106902102A (zh) * | 2017-02-22 | 2017-06-30 | 武汉华士特工业生物技术开发有限公司 | 玛咖酰胺类化合物在制备治疗月经不调药物中的应用 |
EP3831213A1 (en) * | 2019-12-04 | 2021-06-09 | Vegastrade-Comércio de Perfumeria e Bijutaria, LDA | Non-carbonated beverage comprising aloe vera and plant extracts |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103653147B (zh) | 一种小麦肽抗疲劳保健饮料及其制备方法 | |
KR101475138B1 (ko) | 신장 기능 강화 및 부종 개선에 효과적인 아르기닌 강화된 호박 등의 복합물을 유효성분으로 함유하는 조성물 | |
US20080286388A1 (en) | Pharmaceutical Composition and Non Dependence Coffee Comprising Edible Carboxylic Acid and/or Its Acid Salts and Coffeine | |
CN101878908A (zh) | 沙棘果提取物组合保健品及其制备方法 | |
CN103504444A (zh) | 一种灵芝竹荪固体饮料的制备方法 | |
CN102048225B (zh) | 一种具有改善生长发育功能的红枣保健饮料 | |
CN104855994A (zh) | 肾病非全营养配方食品 | |
CN108782874A (zh) | 一种富硒红茶饮料 | |
KR20130056780A (ko) | 한약 농축액과 분말을 이용한 한약 조성물 | |
AU2016201968A1 (en) | Sporoderm-broken ganoderma lucidum spore powder, honey & propolis buccal tablet and manufacturing method thereof | |
CN105495206A (zh) | 给身体充电的植物活力饮料及其制备方法 | |
CN104305453A (zh) | 一种西洋参复合抗疲劳运动保健饮品 | |
KR101456415B1 (ko) | 바 형상의 다이어트용 기능성 식품 제조방법 | |
EP2891496B1 (en) | PHARMACEUTICAL COMPOSITION CONTAINING COMPLEX EXTRACT OF CRATAEGI FRUCTUS and CITRI PERICARPIUM AS AN ACTIVE INGREDIENT FOR TREATING OR PREVENTING OBESITY OR LIPID-RELATED METABOLIC DISEASES | |
JP4812222B2 (ja) | ミネラル吸収促進剤 | |
KR20100067575A (ko) | 해조류 매생이를 함유하는 공진환의 제조 | |
CN1403017A (zh) | 富硒魔芋绿茶保健食品 | |
KR101642176B1 (ko) | 성장촉진 조성물 | |
RU2533040C2 (ru) | Состав для приготовления фитоджема (варианты) | |
US20180169071A1 (en) | Nutritional supplement composition | |
JP7089044B2 (ja) | 骨粗しょう症の予防または治療用組成物 | |
CN106923335A (zh) | 一种运动营养的功能组合物及应用 | |
KR101381277B1 (ko) | 홍삼을 함유하는 고장초 겔 | |
CN105349395A (zh) | 一种山楂果醋的制备方法 | |
CN105961975B (zh) | 一种含有小球藻生长因子的功能饮料及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160420 |